232 related articles for article (PubMed ID: 36741271)
21. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
Wang B; Wang Y; Zhang L; Lu F; Zhang M; Xu Y
Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704741
[TBL] [Abstract][Full Text] [Related]
22. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
[TBL] [Abstract][Full Text] [Related]
23. Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack.
Johnson CJ; Davis JM; Huttenlocher A; Kernien JF; Nett JE
mBio; 2018 Aug; 9(4):. PubMed ID: 30131360
[No Abstract] [Full Text] [Related]
24. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Forsberg K; Woodworth K; Walters M; Berkow EL; Jackson B; Chiller T; Vallabhaneni S
Med Mycol; 2019 Jan; 57(1):1-12. PubMed ID: 30085270
[TBL] [Abstract][Full Text] [Related]
25. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species.
Borman AM; Szekely A; Johnson EM
mSphere; 2016; 1(4):. PubMed ID: 27547827
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
[TBL] [Abstract][Full Text] [Related]
27. Assaying the effect of yeasts on growth of fungi associated with disease.
Horváth E; Sipiczki M; Csoma H; Miklós I
BMC Microbiol; 2020 Oct; 20(1):320. PubMed ID: 33087058
[TBL] [Abstract][Full Text] [Related]
28.
Keighley C; Garnham K; Harch SAJ; Robertson M; Chaw K; Teng JC; Chen SC
Curr Fungal Infect Rep; 2021; 15(3):116-126. PubMed ID: 34178208
[TBL] [Abstract][Full Text] [Related]
29. The Inhibition of Non-
Mandras N; Roana J; Scalas D; Del Re S; Cavallo L; Ghisetti V; Tullio V
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443525
[TBL] [Abstract][Full Text] [Related]
30. First case of
Dewaele K; Frans J; Smismans A; Ho E; Tollens T; Lagrou K
Acta Clin Belg; 2020 Jun; 75(3):221-228. PubMed ID: 30514182
[No Abstract] [Full Text] [Related]
31. Candida glabrata - basic characteristics, virulence, treatment, and resistance.
Eliaš D; Gbelská Y
Epidemiol Mikrobiol Imunol; 2022; 71(2):118-134. PubMed ID: 35940866
[TBL] [Abstract][Full Text] [Related]
32. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia.
Ceballos-Garzón A; Cortes G; Morio F; Zamora-Cruz EL; Linares MY; Ariza BE; Valderrama SL; Garzón JR; Alvarez-Moreno CA; Le Pape P; Parra-Giraldo CM
BMC Microbiol; 2019 May; 19(1):106. PubMed ID: 31122184
[TBL] [Abstract][Full Text] [Related]
33. [Candida auris: The Recent Emergence of a Multiresistant Pathogenic Fungi].
Antunes F; Veríssimo C; Pereira ÁA; Sabino R
Acta Med Port; 2020 Oct; 33(10):680-684. PubMed ID: 33135623
[TBL] [Abstract][Full Text] [Related]
34. Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.
Marcos-Zambrano LJ; Escribano P; Sánchez C; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2014 Aug; 58(8):4565-72. PubMed ID: 24867979
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Candidemia in Kuwait: A Nationwide, Population-Based Study.
Alobaid K; Ahmad S; Asadzadeh M; Mokaddas E; Al-Sweih N; Albenwan K; Alfouzan W; Al-Obaid I; Jeragh A; Al-Roomi E; Khan Z; Joseph L; Varghese S
J Fungi (Basel); 2021 Aug; 7(8):. PubMed ID: 34436212
[TBL] [Abstract][Full Text] [Related]
36. Rezafungin
Helleberg M; Jørgensen KM; Hare RK; Datcu R; Chowdhary A; Arendrup MC
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015032
[TBL] [Abstract][Full Text] [Related]
37.
Hata DJ; Humphries R; Lockhart SR;
Arch Pathol Lab Med; 2020 Jan; 144(1):107-114. PubMed ID: 31169997
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of Autof MS 1000 and Vitek MS MALDI-TOF MS System in Identification of Closely-Related Yeasts Causing Invasive Fungal Diseases.
Yi Q; Xiao M; Fan X; Zhang G; Yang Y; Zhang JJ; Duan SM; Cheng JW; Li Y; Zhou ML; Yu SY; Huang JJ; Chen XF; Hou X; Kong F; Kudinha T; Xu YC
Front Cell Infect Microbiol; 2021; 11():628828. PubMed ID: 33680993
[TBL] [Abstract][Full Text] [Related]
39. Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.
Anh DN; Hung DN; Tien TV; Dinh VN; Son VT; Luong NV; Van NT; Quynh NTN; Van Tuan N; Tuan LQ; Bac ND; Luc NK; Anh LT; Trung DM
BMC Infect Dis; 2021 Jun; 21(1):523. PubMed ID: 34082699
[TBL] [Abstract][Full Text] [Related]
40. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
